Authors: BIALER M ARCAVI L SUSSAN S VOLOSOV A YACOBI A MOROS D LEVITT B LAOR A

Citation: M. Bialer et al., EXISTING AND NEW CRITERIA FOR BIOEQUIVALENCE EVALUATION OF NEW CONTROLLED-RELEASE (CR) PRODUCTS OF CARBAMAZEPINE, Epilepsy research, 32(3), 1998, pp. 371-378

Authors: BIALER M YACOBI A MOROS D LEVITT B HOULE JM MUNSAKA MS

Citation: M. Bialer et al., CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE, Epilepsia, 39(5), 1998, pp. 513-519

Authors: RAINES A FLOCKHART D DRETCHEN KL SINGH A THACKER D YACOBI A MOROS D LEVITT BH ABERNETHY D

Citation: A. Raines et al., CONVERSION OF DIMETHOXYMETHYL-DIPHENYLBARBITURIC ACID (DMMDPB) TO DIPHENYLBARBITURIC ACID (DPB) IN THE RAT, The FASEB journal, 10(3), 1996, pp. 895-895

Authors: MERCHANT CA COHEN G MYTILINEOU C DIROCCO A MOROS D MOLINARI S YAHR MD

Citation: Ca. Merchant et al., HUMAN TRANSPLACENTAL TRANSFER OF CARBIDOPA-LEVODOPA, Journal of neural transmission. Parkinson's disease and dementia section, 9(2-3), 1995, pp. 239-242

Authors: MERCHANT CA COHEN G MYTILINEOUS C DIROCCO A MOLINARI S MOROS D YAHR MD

Citation: Ca. Merchant et al., HUMAN TRANSPLACENTAL TRANSMISSION OF CARBIDOPA LEVODOPA/, Neurology, 44(4), 1994, pp. 10000247-10000248

Authors: SERBY M MOROS D ROWAN J CARLIN L YAHR M

Citation: M. Serby et al., MAINTENANCE ECT AS ADJUNCTIVE TREATMENT TO DOPAMINERGIC DRUGS IN PARKINSONS-DISEASE, Biological psychiatry, 35(9), 1994, pp. 654-654